CNCR
CNCR
About Loncar Cancer Immunotherapy ETF
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index....
About Loncar Cancer Immunotherapy ETF
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index....
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 TIL | Instil Bio, Inc. | 3.59% | 93.23K | $963.40K |
 REPL | Replimune Group, Inc. | 3.54% | 47.19K | $949.98K |
 IOVA | Iovance Biotherapeutics, Inc. | 3.47% | 67.48K | $931.20K |
 ZYME | Zymeworks Inc. | 3.45% | 41.55K | $925.83K |
 GMAB | Genmab A/S | 3.42% | 35.79K | $917.78K |
 ARGX | argenx SE | 3.42% | 5.06K | $917.78K |
 AZN | AstraZeneca PLC | 3.39% | 26.54K | $909.73K |
 BMY | Bristol-Myers Squibb Company | 3.39% | 23.17K | $909.73K |
 CRSP | CRISPR Therapeutics AG | 3.39% | 12.62K | $909.73K |
 XNCR | Xencor, Inc. | 3.37% | 41.93K | $904.36K |
 MRK | Merck & Co., Inc. | 3.37% | 20.51K | $904.36K |
 NKTR | Nektar Therapeutics | 3.37% | 87.53K | $904.36K |
 REGN | Regeneron Pharmaceuticals, Inc. | 3.36% | 2.94K | $901.68K |
 FATE | Fate Therapeutics, Inc. | 3.33% | 17.66K | $893.63K |
 GILD | Gilead Sciences, Inc. | 3.33% | 22.54K | $893.63K |
 RCUS | Arcus Biosciences, Inc. | 3.32% | 62.77K | $890.95K |
 ATRA | Atara Biotherapeutics, Inc. | 3.30% | 108.60K | $885.58K |
 ALLO | Allogene Therapeutics, Inc. | 3.29% | 60.62K | $882.89K |
 IBRX | ImmunityBio, Inc. | 3.28% | 104.74K | $880.21K |
 STTK | Shattuck Labs, Inc. | 3.23% | 53.96K | $866.79K |
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
United States
Canada
Netherlands
Denmark
United Kingdom
SwitzerlandSECTOR HOLDINGS
Healthcare Financial Services Cash & OthersASSET ALLOCATION BY REGION
United States Canada Netherlands Denmark United Kingdom SwitzerlandHoldings (Top 20)
TIL
Instil Bio, Inc.
REPL
Replimune Group, Inc.
IOVA
Iovance Biotherapeutics, Inc.
ZYME
Zymeworks Inc.
GMAB
Genmab A/S
ARGX
argenx SE
AZN
AstraZeneca PLC
BMY
Bristol-Myers Squibb Company
CRSP
CRISPR Therapeutics AG
XNCR
Xencor, Inc.
MRK
Merck & Co., Inc.
NKTR
Nektar Therapeutics
REGN
Regeneron Pharmaceuticals, Inc.
FATE
Fate Therapeutics, Inc.
GILD
Gilead Sciences, Inc.
RCUS
Arcus Biosciences, Inc.
ATRA
Atara Biotherapeutics, Inc.
ALLO
Allogene Therapeutics, Inc.
IBRX
ImmunityBio, Inc.
STTK
Shattuck Labs, Inc.